A. J. Kazimi - Mar 16, 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Mar 16, 2022
Transactions value $
-$50,142
Form type
4
Date filed
4/29/2022, 12:58 PM
Previous filing
Jan 7, 2022
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Award $51.8K +20K +0.35% $2.59 5.79M Mar 16, 2022 Direct F1
transaction CPIX Common Stock Tax liability -$102K -37.2K -0.64% $2.74 5.75M Mar 20, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPIX Options (right to buy) Award $0 +80K $0.00 80K Mar 16, 2022 Common Stock 80K $2.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock award will vest 100% on March 16, 2026.
F2 This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.